Literature DB >> 16570923

Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.

Yunpeng Ye1, Sharon Bloch, Baogang Xu, Samuel Achilefu.   

Abstract

Molecular interactions between RGD peptides and integrins are known to mediate many biological and pathological processes. This has led to an increased interest in the development of RGD compounds with high affinity and improved selectivity for integrin receptors. In this study, we synthesized and evaluated a series of multimeric RGD compounds constructed on a dicarboxylic acid-containing near-infrared (NIR) fluorescent dye (cypate) for tumor targeting. An array of NIR fluorescent RGD compounds was prepared efficiently, including one RGD monomer (cypate-(RGD)(2)-NH(2)), two RGD dimers (cypate-(RGD)(2)-NH(2) and cypate-(RGD-NH(2))(2)), one trimer (cypate-(RGD)(3)-NH(2)), two tetramers (cypate-(RGD)(4)-NH(2) and cypate-[(RGD)(2)-NH(2)](2)), one hexamer (cypate-[(RGD)(3)-NH(2)](2)), and one octamer (cypate-[(RGD)(4)-NH(2)](2)). The binding affinity of the multimeric RGD compounds for alpha(v)beta(3) integrin receptor (ABIR) showed a remarkable increase relative to the monomer cypate-RGD-NH(2). Generally, the divalent linear arrays of the multimeric RGD units bound the ABIR with slightly higher affinity than their monovalent analogues. These results suggest that the receptor binding affinity was not only dependent on the number of RGD moieties but also on the spatial alignments of the pendant peptides. Internalization of the compounds by ABIR-positive tumor cells (A549) was monitored by NIR fluorescence microscopy. The data showed that endocytosis of the octameric RGD derivative was significantly higher by comparison to other compounds in this study. In vivo noninvasive optical imaging and biodistribution data showed that the compounds were retained in A549 tumor tissue. These results clearly demonstrated that an array of simple RGD tripeptides on a NIR fluorescent dye core can be recognized by ABIR. Optimization of the spatial alignment of the RGD moieties through careful molecular design and library construction could induce multivalent ligand-receptor interactions useful for in vivo tumor imaging and tumor-targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570923      PMCID: PMC2525663          DOI: 10.1021/jm050947h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  68 in total

1.  Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.

Authors:  Zhen Cheng; Yun Wu; Zhengming Xiong; Sanjiv Sam Gambhir; Xiaoyuan Chen
Journal:  Bioconjug Chem       Date:  2005 Nov-Dec       Impact factor: 4.774

2.  Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis.

Authors:  Joel J Bergh; Hung-Yun Lin; Lawrence Lansing; Seema N Mohamed; Faith B Davis; Shaker Mousa; Paul J Davis
Journal:  Endocrinology       Date:  2005-03-31       Impact factor: 4.736

Review 3.  GPVI and integrin alphaIIb beta3 signaling in platelets.

Authors:  S P Watson; J M Auger; O J T McCarty; A C Pearce
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

4.  Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein.

Authors:  T V Byzova; W Kim; R J Midura; E F Plow
Journal:  Exp Cell Res       Date:  2000-02-01       Impact factor: 3.905

5.  Photodynamic therapy: tumor targeting with adenoviral proteins.

Authors:  C M Allen; W M Sharman; C La Madeleine; J M Weber; R Langlois; R Ouellet; J E van Lier
Journal:  Photochem Photobiol       Date:  1999-10       Impact factor: 3.421

6.  Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.

Authors:  Torsten Kessler; Ralf Bieker; Teresa Padró; Christian Schwöppe; Thorsten Persigehl; Christoph Bremer; Michael Kreuter; Wolfgang E Berdel; Rolf M Mesters
Journal:  Clin Cancer Res       Date:  2005-09-01       Impact factor: 12.531

7.  A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas.

Authors:  Daniela Taverna; Denise Crowley; Mary Connolly; Roderick T Bronson; Richard O Hynes
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

8.  PMA-enhanced neutrophil [18F]FDG uptake is independent of integrin occupancy but requires PI3K activity.

Authors:  Jin-Young Paik; Bong-Ho Ko; Yearn Seong Choe; Yong Choi; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Biol       Date:  2005-08       Impact factor: 2.408

Review 9.  Integrin signaling in malignant melanoma.

Authors:  Silke Kuphal; Richard Bauer; Anja-Katrin Bosserhoff
Journal:  Cancer Metastasis Rev       Date:  2005-06       Impact factor: 9.264

10.  Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression.

Authors:  Samuel Achilefu; Sharon Bloch; Mary A Markiewicz; Tuoxiu Zhong; Yunpeng Ye; Richard B Dorshow; Britton Chance; Kexian Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

View more
  51 in total

1.  Cell-compatible, integrin-targeted cryptophane-129Xe NMR biosensors.

Authors:  Garry K Seward; Yubin Bai; Najat S Khan; Ivan J Dmochowski
Journal:  Chem Sci       Date:  2011-06       Impact factor: 9.825

2.  Multiphoton microscopy with near infrared contrast agents.

Authors:  Siavash Yazdanfar; Chulmin Joo; Chun Zhan; Mikhail Y Berezin; Walter J Akers; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2010 May-Jun       Impact factor: 3.170

3.  Integrin-targeting block copolymer probes for two-photon fluorescence bioimaging.

Authors:  Sanchita Biswas; Xuhua Wang; Alma R Morales; Hyo-Yang Ahn; Kevin D Belfield
Journal:  Biomacromolecules       Date:  2010-12-29       Impact factor: 6.988

4.  A time domain fluorescence tomography system for small animal imaging.

Authors:  Anand T N Kumar; Scott B Raymond; Andrew K Dunn; Brian J Bacskai; David A Boas
Journal:  IEEE Trans Med Imaging       Date:  2008-08       Impact factor: 10.048

5.  Design and synthesis of an antigenic mimic of the Ebola glycoprotein.

Authors:  Ryan D Rutledge; Brian J Huffman; David E Cliffel; David W Wright
Journal:  J Mater Res       Date:  2008       Impact factor: 3.089

6.  Abrin P2 suppresses proliferation and induces apoptosis of colon cancer cells via mitochondrial membrane depolarization and caspase activation.

Authors:  Ying Yu; Runmei Yang; Xiuyun Zhao; Dandan Qin; Zhaoyang Liu; Fang Liu; Xin Song; Liqin Li; Renqing Feng; Nannan Gao
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-04-06       Impact factor: 3.848

7.  Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imaging.

Authors:  Yunpeng Ye; Walter Akers; Baogang Xu; Sharon Bloch; Charles Odonkor; Samuel Achilefu
Journal:  Bioorg Med Chem Lett       Date:  2012-07-20       Impact factor: 2.823

8.  Migfilin, a molecular switch in regulation of integrin activation.

Authors:  Sujay Subbayya Ithychanda; Mitali Das; Yan-Qing Ma; Keyang Ding; Xiaoxia Wang; Sudhiranjan Gupta; Chuanyue Wu; Edward F Plow; Jun Qin
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

9.  (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.

Authors:  Zi-Bo Li; Kai Chen; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-19       Impact factor: 9.236

Review 10.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.